CH&E Seminar Series: Improved Health Outcomes for Ischemic Stroke Patients Across the Entire Population of Alberta Through a Provincial Door-to-Needle Initiative
Presenter: Noreen Kamal, P.Eng. Ph.D., Assistant Professor, Department of Industrial Engineering, Dalhousie University
Join Zoom Meeting
Meeting ID: 814 6158 1121
Phone: +17789072071,,81461581121# Canada
Abstract: Stroke is a devastating disease, as it is the leading cause of severe disability. Ischemic stroke, the most common type of stroke, is treatable with intravenous alteplase; however, the effectiveness of this treatment is highly time dependent. In stroke minutes matter! A provincial Improvement Collaborative methodology was deployed from April 2015 to September 2016. with a vision to lower door-to-needle times across the province. A full pre-post analysis of the Improvement Collaborative was conducted using data from July 2007 to December 2017. Results show that the percentage of patients discharged home from acute care increased from 45.6% to 59.5% (P<0.0001), and the in-hospital mortality decreased from 14.5% to 10.5% (P=0.0990). An overview of how this research will be translated to Atlantic Canada through the ACTEAST (Atlantic Canada Together Enhancing Acute Stroke Treatment) project will be discussed.
Speaker Bio: Dr. Noreen Kamal is an Assistant Professor in the Department of Industrial Engineering at Dalhousie University. Her primary area of research is improving the quality of health care with a vision to match health system processes to the progression of the disease. She has been working to improve the efficiency of acute stroke treatment in Alberta and now across Atlantic Canada. Her research also includes modeling the optimal destination for suspected stroke patients to access Endovascular Treatment, which led to commercialization of a cloud-based interactive software that has been used by health care administrators in Europe, the US and Asia. Through the development of this software, she is co-founder of DESTINE Health Inc.